FP
AGN

Foundry Partners’s Allergan plc AGN Stock Holding History

Foundry Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-127,845
Closed -$21.4M – 417
2019
Q2 		$21.4M Buy
127,845
+1,175
+0.9% +$163K 0.84% 20
2019
Q1 		$18.5M Buy
126,670
+1,975
+2% +$286K 0.74% 27
2018
Q4 		$16.7M Buy
124,695
+30,842
+33% +$5.06M 0.75% 25
2018
Q3 		$17.9M Buy
93,853
+48,803
+108% +$8.97M 0.68% 27
2018
Q2 		$7.51M Buy
+45,050
New +$7.23M 0.31% 125
2017
Q2 		– Sell
-1,757
Closed -$420K – 457
2017
Q1 		$420K Sell
1,757
-550
-24% -$128K 0.02% 382
2016
Q4 		$484K Sell
2,307
-5,423
-70% -$1.12M 0.02% 381
2016
Q3 		$1.78M Sell
7,730
-2,065
-21% -$505K 0.09% 270
2016
Q2 		$2.26M Sell
9,795
-1,455
-13% -$335K 0.13% 252
2016
Q1 		$3.02M Sell
11,250
-11,235
-50% -$3.22M 0.3% 107
2015
Q4 		$7.03M Sell
22,485
-199
-0.9% -$59.2K 0.58% 56
2015
Q3 		$6.17M Sell
22,684
-6,628
-23% -$2.04M 0.54% 65
2015
Q2 		$8.89M Sell
29,312
-3,556
-11% -$1.06M 0.71% 41
2015
Q1 		$9.78M Buy
+32,868
New +$9.37M 0.81% 38

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Foundry Partners's AGN Position: Q3 2019 in Review

Foundry Partners sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 127,845 shares — an estimated $21.4M sold.

Foundry Partners first reported a position in AGN in Q1 2015 and held it in 14 quarters. The position peaked at $21.4M in Q2 2019. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Foundry Partners reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Foundry Partners sold 127,845 Allergan plc shares in Q3 2019, an estimated $21.4M.
  • Foundry Partners first reported a position in Allergan plc in Q1 2015 and held it in 14 quarters.
  • Foundry Partners's Allergan plc position peaked at $21.4M in Q2 2019.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Foundry Partners's 13F filing for Q3 2019, filed 23 Oct 2019.